CTOs on the Move

Acucela

www.acucela.com

 
Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million
  • www.acucela.com
  • 1301 2nd Ave # 1900
    Seattle, WA USA 98101
  • Phone: 206.805.8300

Executives

Name Title Contact Details

Similar Companies

Research Diets

Research Diets is a New Brunswick, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Coffey Communications Inc

Coffey Communications, Inc., is the leading provider of custom communication products for the health care industry. For more than 19 years, we have been providing clients with a full line of communication tools including: Publications for hospitals and

Bewell Network

The best inpatient drug rehabs Los Angeles options offering evidence-based, personalized addiction treatment. Our alcohol detox centers LA

Value Drug Company

Value Drug Company, founded in 1934 and incorporated in 1936, is a wholesale purchasing cooperative of Independent Pharmacies.

TheraNova

TheraNova is a San Francisco, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.